
This center is one of the few licensed stem cell manufacturing facilities in Europe. It can produce stem cells for the treatment of arthritis, heart disease, diabetes, and their complications, and is currently conducting clinical trials on mesenchymal stem cells. Mesenchymal stem cells are extracted and cultured from adult bone marrow and can be used to treat diabetes complications—specifically critical limb ischemia, a condition that can lead to amputation if it progresses to a severe stage. According to the National University of Ireland, Galway, there are currently over 1,900 cell therapy clinical trials underway globally.



